Among these agents NO donors, treatment of tumor cells with low expression of RKIP and resistant to cytotoxic drugs resulted in the induction of RKIP and the sensitization to both chemo- and immune-therapeutics. This evidence concerns the gene PEBP1 and neoplasm.